Jazz Pharmaceuticals
JAZZ
#1923
Rank
โ‚น911.31 B
Marketcap
โ‚น14,997
Share price
-0.11%
Change (1 day)
43.42%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚น60.21 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚น4.15 Billion. In 2024 the company made an earning of โ‚น42.26 Billion, an increase over its 2023 earnings that were of โ‚น26.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น60.21 Billion-242.45%
2024 โ‚น42.26 B57.87%
2023 โ‚น26.76 B-179.92%
2022 -โ‚น33.5 Billion230.37%
2021 -โ‚น10.14 Billion-141.02%
2020 โ‚น24.71 B-39.45%
2019 โ‚น40.82 B-14.2%
2018 โ‚น47.57 B20.03%
2017 โ‚น39.63 B-17.15%
2016 โ‚น47.84 B22.14%
2015 โ‚น39.16 B187.64%
2014 โ‚น13.61 B-50.79%
2013 โ‚น27.67 B73.63%
2012 โ‚น15.93 B41.69%
2011 โ‚น11.24 B116.61%
2010 โ‚น5.19 B262.77%
2009 โ‚น1.43 B-111.33%
2008 -โ‚น12.64 Billion1.31%
2007 -โ‚น12.47 Billion77.8%
2006 -โ‚น7.02 Billion36.59%
2005 -โ‚น5.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Endo International
ENDPQ
-โ‚น214.93 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
โ‚น188.39 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.475 T-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚น159.21 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel